Endeavor BioMedicines’ Post

View organization page for Endeavor BioMedicines, graphic

2,675 followers

#InTheNews: After presenting new data from our Phase 2a #clinicaltrial of ENV-101, investigator Toby Maher, M.D., Ph.D., Professor of Medicine and Director of Interstitial Lung Disease at Keck School of Medicine of the University of Southern California discussed the findings with Healio.    In this article, hear Dr. Maher’s perspective on the tremendous need for idiopathic pulmonary fibrosis (#IPF) treatments that do more than slow the decline of lung function and why #pulmonologists are keeping a close eye on Endeavor’s ENV-101: https://bit.ly/3VrSNvr    #biotechnews #science #lungdisease 

  • No alternative text description for this image
Donna Weller

Research Associate II

1mo

😊

Like
Reply
Linda Scheer, MD

Medical Affairs Professional seeking new opportunity including Freelance Consulting and Virtual Medical Affairs/ MSL support.

1mo

Congratulations Endeavor!

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics